Bogle Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bogle Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-148,326	Closed	-$17.5M	–	509
2015 Q3	$17.5M	Sell	148,326 -23,456	-14%	-$3.06M	1.24%	2
2015 Q2	$13.3M	Sell	171,782 -57,017	-25%	-$3.74M	0.99%	10
2015 Q1	$13.2M	Sell	228,799 -34,759	-13%	-$1.48M	0.91%	24
2014 Q4	$8.5M	Buy	+263,558	New	+$7.91M	0.56%	65
2014 Q1	–	Sell	-180,437	Closed	-$3.03M	–	460
2013 Q4	$3.03M	Buy	+180,437	New	+$2.5M	0.26%	130

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bogle Investment Management's ANAC Position: Q4 2015 in Review

Bogle Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 148,326 shares — an estimated $17.5M sold.

Bogle Investment Management first reported a position in ANAC in Q4 2013 and held it in 5 quarters. The position peaked at $17.5M in Q3 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

Bogle Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
Bogle Investment Management sold 148,326 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $17.5M.
Bogle Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 5 quarters.
Bogle Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $17.5M in Q3 2015.
214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on Bogle Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.